Read more from PHG Foundation Director, Dr Mark Kroese, in the blog Moving innovations from hype to healthcare >>
Genomics has always been a priority focus for the PHG Foundation, and as we heard at our conference From Hype To Healthcare, continues to offer new opportunities for health. One the biggest achievements so far is the establishment in the UK of National Genomic Medicine Service – a world first. Prof Dame Sue Hill set out the journey so far and how it is contributing to more personalised medicine. Genomics isn’t the only technology of course and Sue highlighted those identified in the PHG Foundation report The personalised medicine technologies landscape. The executive summary and full report are free to download.
Novel science and technologies offer genuinely exciting opportunities to change and improve healthcare, but how do we move from understanding potential to real world delivery? Jess Morley from NHSX and Dr Sarah Byron from NICE looked at the reality of moving healthcare innovations into clinical practice. Jess’s talk on the risks and benefits of AI chimed nicely with the work we are doing on the regulation of algorithms and medical devices
Even obviously good health innovations need careful assessment of their probable impacts to prepare the way for their use. The afternoon parallel sessions examined different complexities arising from the application of science and technology within healthcare.
In parallel A , the panel of Dr Helen O'Neill, Julian Hitchock and Dr Laura Blackburn explored the therapeutic options offered by genome editing – and policy barriers that may stand in the way. PHG Foundation has been monitoring the progress of genome editing and its implementation into health servcies, collated under genome editing.
Meanwhile, Dr Mark Bale, Dr Stephen Lee and Dr Philippa Brice how can policy-makers operating in a pressured environment successfully manage rapid developments in the applications of science for health? Dr Philippa Brice blogs regularly on healthcare policy.
How health services can make the most of big data whilst maximising the medical benefits in a responsible way was the topic up for discussion by Dr Neal J Meropol, Rose Gray and Alison Hall. The ethics and practicalities of generating, using and sharing data to improve health services is a significant focus for our work, which you can find under big data and health data.
Transformational change requires more than just innovation. The final session took a different stance on the insights arising from new and emerging scientific understanding to imagine what the future might look like for specific areas of medicine, and how we can get there. Prof Sir Mark Caulfield opened with an outline of the lessons learned from the 100,000 Genomes Project before detailing where he expects genomics to have most impact in the new future - namely in rare diseases, newborn screening and cancer.
Thank you to all the speakers and delegates who contributed so much to the success of the day, and to our generous event sponsors, Roche.
See the Twitter highlights from the day